1Tellez G, Benson AB, Lyster MT, et al. Phase Ⅱ trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature Cancer,1998: 82(7) : 1250.
2Liu SKM, Church JM, Lavery IC.Operation in pationts with incurabie colon cancer - Is it worth while? Dis Color Rectum, 1997: 40(1): 11.
3Greenway B, Hepatic metastasis form colorectal cancer: resection or not.B J Surg, 1988: 75(6) : 513.
4Que FG, Nagorney DM, Resection of "recurrent" colonrectal metastases to the liver.B J Surg, 1994: 81(2): 255.
5Leichman CG, Fleming TR, Maggia FM, et al. Phase Ⅱ study of fluovouracil and its modulation in advanced colorectal cancer: Southwest Oncology Group Study.J Clin Oncol,1995: 13:1303.
6Wadler S. The role of interferous in the treatment of solid tumors Cnacer, 1992: 70(4): 949.
7Wadler S, Lemhersky B, Atkins M, et al. Phase Ⅱ trial of fluorouracil and recombinant interferon alfa - 2a in patients with advanced colorectal carcinoma: an eastern cooperative oncology group study J Clin Oncol, 1991: 9(10) : 1806.
8Kemeny N, Schneider A.Regional treatment of hepatic metastases and hepatocellar carcinoma. Curr Problems Cancer, 1989: 13(4): 210.
9Lang EK, Brown CL.Colorectal metastases to the liver: selective chemoembolization. Radiology, 1993 : 189(2) : 417.
